1. Winquist RJ, Kwong A, Ramachandran R, Jain J. The complex etiology of multiple sclerosis. Biochem Pharmacol. 2007; 74:1321–1329.
2. Kingwell E, Bajdik C, Phillips N, Zhu F, Oger J, Hashimoto S, Tremlett H. Cancer risk in multiple sclerosis: findings from British Columbia, Canada. Brain. 2012; 135:2973–2979.
3. Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, Fereidan-Esfahani M. Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol. 2013; 70:356–363.
4. Sandyk R, Awerbuch GI. Vitamin B12 and its relationship to age of onset of multiple sclerosis. Int J Neurosci. 1993; 71:93–99.
5. Idiman E, Uzunel F, Ozakbas S, Yozbatiran N, Oguz M, Callioglu B, Gokce N, Bahar Z. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. J Neurol Sci. 2006; 240:77–80.
6. Holmøy T, Torkildsen Ø, Myhr KM. An update on cladribine for relapsing-remitting multiple sclerosis. Expert Opin Pharmacother. 2017; 18:1627–1635.
7. Morgante L. Hope in multiple sclerosis: a nursing perspective. Int J MS Care. 2000; 2:9–15.
8. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995; 4:187–206.
9. Miller DM, Rudick RA, Baier M, Cutter G, Doughtery DS, Weinstock-Guttman B, Mass MK, Fisher E, Simonian N. Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler. 2003; 9:1–5.
11. Ashtari F, Abari SS, ShayganNejad V. Serum homocysteine level in patients with multiple sclerosis. J Res Med Sci. 2005; 10:302–304.
12. Moghaddasi M, Mamarabadi M, Mohebi N, Razjouyan H, Aghaei M. Homocysteine, vitamin B12 and folate levels in Iranian patients with multiple sclerosis: a case control study. Clin Neurol Neurosurg. 2013; 115:1802–1805.
14. Reynolds EH. Multiple sclerosis and vitamin B12 metabolism. J Neurol Neurosurg Psychiatry. 1992; 55:339–340.
15. Kocer B, Engur S, Ak F, Yilmaz M. Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis. J Clin Neurosci. 2009; 16:399–403.
16. Gupta JK, Ingegno AP, Cook AW, Pertschuk LP. Multiple sclerosis and malabsorption. Am J Gastroenterol. 1977; 68:560–565.
17. Zhu Y, He ZY, Liu HN. Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis. J Clin Neurosci. 2011; 18:933–938.
18. Hamilton M, Blackmore S. Chapter 8. Investigation of megaloblastic anaemia-cobalamin, folate, and metabolite status. In : Lewis SM, Bain BJ, Bates I, Dacie JV, editors. Dacie and Lewis Practical Haematology. 10th ed. Philadelphia (PA): Churchill Livingstone Elsevier;2006. p. 161–185.
19. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005; 58:840–846.
20. Ghaem H, Borhani Haghighi A, Jafari P, Nikseresht AR. Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire. Neurol India. 2007; 55:369–375.
22. Madani H, Navipoor H, Roozbayani P. Effect of self-care program on the self-esteem of multiple sclerosis patients. ZUMS J. 2002; 10:47–50.
23. Pietro KJ, Jensen AM, Schumacher JR, Anderson JW. Vitamin B12 intake correlated to physical and mental improvements in multiple sclerosis specific quality of life. Int J Adv Nutr Health Sci. 2014; 2:98–108.
24. Zhang M, Han W, Hu S, Xu H. Methylcobalamin: a potential vitamin of pain killer. Neural Plast. 2013; 2013:424651.
25. Sivakumar B, Nair KM, Sreeramulu D, Suryanarayana P, Ravinder P, Shatrugna V, Kumar PA, Raghunath M, Rao VV, Balakrishna N, Kumar PU, Raghuramulu N. Effect of micronutrient supplement on health and nutritional status of schoolchildren: biochemical status. Nutrition. 2006; 22:S15–25.
26. Kira J, Tobimatsu S, Goto I. Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis. Intern Med. 1994; 33:82–86.
27. Baig SM, Ali Qureshi G. Homocysteine and vitamin B12 in multiple sclerosis. Biog Amines. 1995; 11:479–485.
28. Besler HT, Comoğlu S. Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci. 2003; 6:189–196.
29. Shidfar F, Homayounfar R, Fereshtehnejad SM, Kalani A. Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial. Arch Med Res. 2009; 40:380–386.
30. Kargiotis O, Paschali A, Messinis L, Papathanasopoulos P. Quality of life in multiple sclerosis: effects of current treatment options. Int Rev Psychiatry. 2010; 22:67–82.
31. Reynolds EH, Bottiglieri T, Laundy M, Crellin RF, Kirker SG. Vitamin B12 metabolism in multiple sclerosis. Arch Neurol. 1992; 49:649–652.
32. Plum CM. Studies in multiple sclerosis. I. Acta Psychiatr Neurol Scand Suppl. 1959; 128:1–94.
33. Crellin RF, Bottiglieri T, Reynolds EH. Multiple sclerosis and macrocytosis. Acta Neurol Scand. 1990; 81:388–391.
35. Deleva NS. Multiple sclerosis associated with anaemic syndrome: a retrospective analysis and literature review. J IMAB. 2012; 18:203–205.
36. van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol. 2001; 21:2072–2079.